Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | SREBF2 | Q12772 | 1/20 | 0.37 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | STAT1 | P42224 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27574509 | 0.89 | TP53 (0.47) | KMT2ATP53ALOX15MAPK1PTGS2 | |
| SCHEMBL28329506 | 0.86 | TP53 (0.45) | KMT2ATP53ALOX15MAPK1 | |
| SCHEMBL27824748 | 0.86 | TP53 (0.45) | KMT2ATP53ALOX15MAPK1 | |
| SCHEMBL1408548 | 0.81 | TP53 (0.54) | KMT2ATP53ALOX15MAPK1PTGS2 | |
| SCHEMBL19861974 | 0.81 | DHFR (0.42) | KMT2ATP53ALOX15MAPK1PTGS2 | |
| SCHEMBL5111011 | 0.76 | TP53 (0.57) | KMT2ATP53ALOX15MAPK1PTGS2 | |
| SCHEMBL7386191 | 0.76 | KMT2A (0.53) | KMT2ATP53ALOX15MAPK1PTGS2 | |
| SCHEMBL27659211 | 0.76 | TP53 (0.53) | KMT2ATP53ALOX15MAPK1PTGS2 | |
| SCHEMBL4585925 | 0.76 | LTA4H (0.38) | KMT2AALOX15SREBF2MAPTALDH1A1 | |
| SCHEMBL14948637 | 0.75 | LIPG (0.39) | KMT2ATP53ALOX15MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3842074-A1 | PROTEIN-DRUG CONJUGATES | Philogen S.p.A. (IT) | 2021-06-30 | — | — | EP | disclosed |
| US-9198979-B2 | Thiazolidine linker for the conjugation of drugs to antibodies | PHILOGEN S.P.A. (IT) | 2015-12-01 | — | — | US | disclosed |
| US-20130309257-A1 | Thiazolidine Linker for the Conjugation of Drugs to Antibodies | PHILOGEN S.P.A. (IT) | 2013-11-21 | — | — | US | disclosed |
| EP-2621535-A1 | THIAZOLIDINE LINKER FOR THE CONJUGATION OF DRUGS TO ANTIBODIES | Philogen S.p.A. (IT) | 2013-08-07 | — | — | EP | disclosed |
| WO-2012041451-A1 | THIAZOLIDINE LINKER FOR THE CONJUGATION OF DRUGS TO ANTIBODIES | PHILOGEN S.P.A. (IT) | 2012-04-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130309257-A1 | Thiazolidine Linker for the Conjugation of Drugs to Antibodies | MTCL3, TBCD, TUBB3 | KMT2A 2239/4885TP53 1358/4885ALOX15 4810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.